The global market for Quetiapine Fumarate was estimated to be worth US$ 159.7 million in 2023 and is forecast to a readjusted size of US$ 136.4 million by 2030 with a CAGR of -2.2% during the forecast period 2024-2030

Quetiapine Fumarate - Market

Quetiapine Fumarate is an atypical antipsychotic drug used to treat psychiatric disorders such as schizophrenia, bipolar disorder and depression. It may be used alone or in combination with other psychiatric medications. It is taken orally, and is available only by prescription, under the supervision of a medical practitioner.

Europe is the largest Quetiapine Fumarate market with about 92% market share. China is follower, accounting for about 2% market share.

The key players are AstraZeneca, Intas, TAPI, Accord, Hexal, Dr.Reddy's, Lupin, Sun Pharmaceutical, Hunan Dongting Pharm, SuZhou NO.4 Phamaceutical Factory, Fuan Pharmaceutical, Zhejiang Supor Pharmaceuticals, Zhejiang Huahai Pharmaceutical etc. Top 3 companies occupied about 74% market share.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Quetiapine Fumarate, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Quetiapine Fumarate by region & country, by Type, and by Application.

The Quetiapine Fumarate market size, estimations, and forecasts are provided in terms of sales volume (MT) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Quetiapine Fumarate.

Market Segmentation

Scope of Quetiapine Fumarate - Market Report

Report Metric	Details
Report Name	Quetiapine Fumarate - Market
Forecasted market size in 2030	US$ 136.4 million
CAGR	92
Forecasted years	2024 - 2030
Segment by Type:	Immediate Release Tablets Extended Release Tablets
Segment by Application	Adult Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	AstraZeneca, Intas, TAPI, Accord, Hexal, Dr.Reddy's, Lupin, Sun Pharmaceutical, Hunan Dongting Pharm, SuZhou NO.4 Phamaceutical Factory, Fuan Pharmaceutical, Zhejiang Supor Pharmaceuticals, Zhejiang Huahai Pharmaceutical
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Quetiapine Fumarate manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Quetiapine Fumarate in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Quetiapine Fumarate in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

FAQ for this report

What is the Quetiapine Fumarate - Market size in 2030?

Ans: The Quetiapine Fumarate - Market size in 2030 will be US$ 136.4 million.

What is the Quetiapine Fumarate - Market share by region?

Ans: China is follower, accounting for about 2% market share.

What is the market share of major companies in Quetiapine Fumarate - Market?

Ans: Top 3 companies occupied about 74% market share.

Who are the main players in the Quetiapine Fumarate - Market report?

Ans: The main players in the Quetiapine Fumarate - Market are AstraZeneca, Intas, TAPI, Accord, Hexal, Dr.Reddy's, Lupin, Sun Pharmaceutical, Hunan Dongting Pharm, SuZhou NO.4 Phamaceutical Factory, Fuan Pharmaceutical, Zhejiang Supor Pharmaceuticals, Zhejiang Huahai Pharmaceutical

What are the Application segmentation covered in the Quetiapine Fumarate - Market report?

Ans: The Applications covered in the Quetiapine Fumarate - Market report are Adult, Others

What are the Type segmentation covered in the Quetiapine Fumarate - Market report?

Ans: The Types covered in the Quetiapine Fumarate - Market report are Immediate Release Tablets, Extended Release Tablets

1 Market Overview

1.1 Quetiapine Fumarate Product Introduction

1.2 Global Quetiapine Fumarate Market Size Forecast

1.2.1 Global Quetiapine Fumarate Sales Value (2019-2030)

1.2.2 Global Quetiapine Fumarate Sales Volume (2019-2030)

1.2.3 Global Quetiapine Fumarate Sales Price (2019-2030)

1.3 Quetiapine Fumarate Market Trends & Drivers

1.3.1 Quetiapine Fumarate Industry Trends

1.3.2 Quetiapine Fumarate Market Drivers & Opportunity

1.3.3 Quetiapine Fumarate Market Challenges

1.3.4 Quetiapine Fumarate Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Quetiapine Fumarate Players Revenue Ranking (2023)

2.2 Global Quetiapine Fumarate Revenue by Company (2019-2024)

2.3 Global Quetiapine Fumarate Players Sales Volume Ranking (2023)

2.4 Global Quetiapine Fumarate Sales Volume by Company Players (2019-2024)

2.5 Global Quetiapine Fumarate Average Price by Company (2019-2024)

2.6 Key Manufacturers Quetiapine Fumarate Manufacturing Base Distribution and Headquarters

2.7 Key Manufacturers Quetiapine Fumarate Product Offered

2.8 Key Manufacturers Time to Begin Mass Production of Quetiapine Fumarate

2.9 Quetiapine Fumarate Market Competitive Analysis

2.9.1 Quetiapine Fumarate Market Concentration Rate (2019-2024)

2.9.2 Global 5 and 10 Largest Manufacturers by Quetiapine Fumarate Revenue in 2023

2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Quetiapine Fumarate as of 2023)

2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type

3.1 Introduction by Type

3.1.1 Immediate Release Tablets

3.1.2 Extended Release Tablets

3.2 Global Quetiapine Fumarate Sales Value by Type

3.2.1 Global Quetiapine Fumarate Sales Value by Type (2019 VS 2023 VS 2030)

3.2.2 Global Quetiapine Fumarate Sales Value, by Type (2019-2030)

3.2.3 Global Quetiapine Fumarate Sales Value, by Type (%) (2019-2030)

3.3 Global Quetiapine Fumarate Sales Volume by Type

3.3.1 Global Quetiapine Fumarate Sales Volume by Type (2019 VS 2023 VS 2030)

3.3.2 Global Quetiapine Fumarate Sales Volume, by Type (2019-2030)

3.3.3 Global Quetiapine Fumarate Sales Volume, by Type (%) (2019-2030)

3.4 Global Quetiapine Fumarate Average Price by Type (2019-2030)

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Adult

4.1.2 Others

4.2 Global Quetiapine Fumarate Sales Value by Application

4.2.1 Global Quetiapine Fumarate Sales Value by Application (2019 VS 2023 VS 2030)

4.2.2 Global Quetiapine Fumarate Sales Value, by Application (2019-2030)

4.2.3 Global Quetiapine Fumarate Sales Value, by Application (%) (2019-2030)

4.3 Global Quetiapine Fumarate Sales Volume by Application

4.3.1 Global Quetiapine Fumarate Sales Volume by Application (2019 VS 2023 VS 2030)

4.3.2 Global Quetiapine Fumarate Sales Volume, by Application (2019-2030)

4.3.3 Global Quetiapine Fumarate Sales Volume, by Application (%) (2019-2030)

4.4 Global Quetiapine Fumarate Average Price by Application (2019-2030)

5 Segmentation by Region

5.1 Global Quetiapine Fumarate Sales Value by Region

5.1.1 Global Quetiapine Fumarate Sales Value by Region: 2019 VS 2023 VS 2030

5.1.2 Global Quetiapine Fumarate Sales Value by Region (2019-2024)

5.1.3 Global Quetiapine Fumarate Sales Value by Region (2025-2030)

5.1.4 Global Quetiapine Fumarate Sales Value by Region (%), (2019-2030)

5.2 Global Quetiapine Fumarate Sales Volume by Region

5.2.1 Global Quetiapine Fumarate Sales Volume by Region: 2019 VS 2023 VS 2030

5.2.2 Global Quetiapine Fumarate Sales Volume by Region (2019-2024)

5.2.3 Global Quetiapine Fumarate Sales Volume by Region (2025-2030)

5.2.4 Global Quetiapine Fumarate Sales Volume by Region (%), (2019-2030)

5.3 Global Quetiapine Fumarate Average Price by Region (2019-2030)

5.4 North America

5.4.1 North America Quetiapine Fumarate Sales Value, 2019-2030

5.4.2 North America Quetiapine Fumarate Sales Value by Country (%), 2023 VS 2030

5.5 Europe

5.5.1 Europe Quetiapine Fumarate Sales Value, 2019-2030

5.5.2 Europe Quetiapine Fumarate Sales Value by Country (%), 2023 VS 2030

5.6 Asia Pacific

5.6.1 Asia Pacific Quetiapine Fumarate Sales Value, 2019-2030

5.6.2 Asia Pacific Quetiapine Fumarate Sales Value by Country (%), 2023 VS 2030

5.7 South America

5.7.1 South America Quetiapine Fumarate Sales Value, 2019-2030

5.7.2 South America Quetiapine Fumarate Sales Value by Country (%), 2023 VS 2030

5.8 Middle East & Africa

5.8.1 Middle East & Africa Quetiapine Fumarate Sales Value, 2019-2030

5.8.2 Middle East & Africa Quetiapine Fumarate Sales Value by Country (%), 2023 VS 2030

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Quetiapine Fumarate Sales Value Growth Trends, 2019 VS 2023 VS 2030

6.2 Key Countries/Regions Quetiapine Fumarate Sales Value

6.2.1 Key Countries/Regions Quetiapine Fumarate Sales Value, 2019-2030

6.2.2 Key Countries/Regions Quetiapine Fumarate Sales Volume, 2019-2030

6.3 United States

6.3.1 United States Quetiapine Fumarate Sales Value, 2019-2030

6.3.2 United States Quetiapine Fumarate Sales Value by Type (%), 2023 VS 2030

6.3.3 United States Quetiapine Fumarate Sales Value by Application, 2023 VS 2030

6.4 Europe

6.4.1 Europe Quetiapine Fumarate Sales Value, 2019-2030

6.4.2 Europe Quetiapine Fumarate Sales Value by Type (%), 2023 VS 2030

6.4.3 Europe Quetiapine Fumarate Sales Value by Application, 2023 VS 2030

6.5 China

6.5.1 China Quetiapine Fumarate Sales Value, 2019-2030

6.5.2 China Quetiapine Fumarate Sales Value by Type (%), 2023 VS 2030

6.5.3 China Quetiapine Fumarate Sales Value by Application, 2023 VS 2030

6.6 Japan

6.6.1 Japan Quetiapine Fumarate Sales Value, 2019-2030

6.6.2 Japan Quetiapine Fumarate Sales Value by Type (%), 2023 VS 2030

6.6.3 Japan Quetiapine Fumarate Sales Value by Application, 2023 VS 2030

6.7 South Korea

6.7.1 South Korea Quetiapine Fumarate Sales Value, 2019-2030

6.7.2 South Korea Quetiapine Fumarate Sales Value by Type (%), 2023 VS 2030

6.7.3 South Korea Quetiapine Fumarate Sales Value by Application, 2023 VS 2030

6.8 Southeast Asia

6.8.1 Southeast Asia Quetiapine Fumarate Sales Value, 2019-2030

6.8.2 Southeast Asia Quetiapine Fumarate Sales Value by Type (%), 2023 VS 2030

6.8.3 Southeast Asia Quetiapine Fumarate Sales Value by Application, 2023 VS 2030

6.9 India

6.9.1 India Quetiapine Fumarate Sales Value, 2019-2030

6.9.2 India Quetiapine Fumarate Sales Value by Type (%), 2023 VS 2030

6.9.3 India Quetiapine Fumarate Sales Value by Application, 2023 VS 2030

7 Company Profiles

7.1 AstraZeneca

7.1.1 AstraZeneca Company Information

7.1.2 AstraZeneca Introduction and Business Overview

7.1.3 AstraZeneca Quetiapine Fumarate Sales, Revenue and Gross Margin (2019-2024)

7.1.4 AstraZeneca Quetiapine Fumarate Product Offerings

7.1.5 AstraZeneca Recent Development

7.2 Intas

7.2.1 Intas Company Information

7.2.2 Intas Introduction and Business Overview

7.2.3 Intas Quetiapine Fumarate Sales, Revenue and Gross Margin (2019-2024)

7.2.4 Intas Quetiapine Fumarate Product Offerings

7.2.5 Intas Recent Development

7.3 TAPI

7.3.1 TAPI Company Information

7.3.2 TAPI Introduction and Business Overview

7.3.3 TAPI Quetiapine Fumarate Sales, Revenue and Gross Margin (2019-2024)

7.3.4 TAPI Quetiapine Fumarate Product Offerings

7.3.5 TAPI Recent Development

7.4 Accord

7.4.1 Accord Company Information

7.4.2 Accord Introduction and Business Overview

7.4.3 Accord Quetiapine Fumarate Sales, Revenue and Gross Margin (2019-2024)

7.4.4 Accord Quetiapine Fumarate Product Offerings

7.4.5 Accord Recent Development

7.5 Hexal

7.5.1 Hexal Company Information

7.5.2 Hexal Introduction and Business Overview

7.5.3 Hexal Quetiapine Fumarate Sales, Revenue and Gross Margin (2019-2024)

7.5.4 Hexal Quetiapine Fumarate Product Offerings

7.5.5 Hexal Recent Development

7.6 Dr.Reddy's

7.6.1 Dr.Reddy's Company Information

7.6.2 Dr.Reddy's Introduction and Business Overview

7.6.3 Dr.Reddy's Quetiapine Fumarate Sales, Revenue and Gross Margin (2019-2024)

7.6.4 Dr.Reddy's Quetiapine Fumarate Product Offerings

7.6.5 Dr.Reddy's Recent Development

7.7 Lupin

7.7.1 Lupin Company Information

7.7.2 Lupin Introduction and Business Overview

7.7.3 Lupin Quetiapine Fumarate Sales, Revenue and Gross Margin (2019-2024)

7.7.4 Lupin Quetiapine Fumarate Product Offerings

7.7.5 Lupin Recent Development

7.8 Sun Pharmaceutical

7.8.1 Sun Pharmaceutical Company Information

7.8.2 Sun Pharmaceutical Introduction and Business Overview

7.8.3 Sun Pharmaceutical Quetiapine Fumarate Sales, Revenue and Gross Margin (2019-2024)

7.8.4 Sun Pharmaceutical Quetiapine Fumarate Product Offerings

7.8.5 Sun Pharmaceutical Recent Development

7.9 Hunan Dongting Pharm

7.9.1 Hunan Dongting Pharm Company Information

7.9.2 Hunan Dongting Pharm Introduction and Business Overview

7.9.3 Hunan Dongting Pharm Quetiapine Fumarate Sales, Revenue and Gross Margin (2019-2024)

7.9.4 Hunan Dongting Pharm Quetiapine Fumarate Product Offerings

7.9.5 Hunan Dongting Pharm Recent Development

7.10 SuZhou NO.4 Phamaceutical Factory

7.10.1 SuZhou NO.4 Phamaceutical Factory Company Information

7.10.2 SuZhou NO.4 Phamaceutical Factory Introduction and Business Overview

7.10.3 SuZhou NO.4 Phamaceutical Factory Quetiapine Fumarate Sales, Revenue and Gross Margin (2019-2024)

7.10.4 SuZhou NO.4 Phamaceutical Factory Quetiapine Fumarate Product Offerings

7.10.5 SuZhou NO.4 Phamaceutical Factory Recent Development

7.11 Fuan Pharmaceutical

7.11.1 Fuan Pharmaceutical Company Information

7.11.2 Fuan Pharmaceutical Introduction and Business Overview

7.11.3 Fuan Pharmaceutical Quetiapine Fumarate Sales, Revenue and Gross Margin (2019-2024)

7.11.4 Fuan Pharmaceutical Quetiapine Fumarate Product Offerings

7.11.5 Fuan Pharmaceutical Recent Development

7.12 Zhejiang Supor Pharmaceuticals

7.12.1 Zhejiang Supor Pharmaceuticals Company Information

7.12.2 Zhejiang Supor Pharmaceuticals Introduction and Business Overview

7.12.3 Zhejiang Supor Pharmaceuticals Quetiapine Fumarate Sales, Revenue and Gross Margin (2019-2024)

7.12.4 Zhejiang Supor Pharmaceuticals Quetiapine Fumarate Product Offerings

7.12.5 Zhejiang Supor Pharmaceuticals Recent Development

7.13 Zhejiang Huahai Pharmaceutical

7.13.1 Zhejiang Huahai Pharmaceutical Company Information

7.13.2 Zhejiang Huahai Pharmaceutical Introduction and Business Overview

7.13.3 Zhejiang Huahai Pharmaceutical Quetiapine Fumarate Sales, Revenue and Gross Margin (2019-2024)

7.13.4 Zhejiang Huahai Pharmaceutical Quetiapine Fumarate Product Offerings

7.13.5 Zhejiang Huahai Pharmaceutical Recent Development

8 Industry Chain Analysis

8.1 Quetiapine Fumarate Industrial Chain

8.2 Quetiapine Fumarate Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.2.3 Manufacturing Cost Structure

8.3 Midstream Analysis

8.4 Downstream Analysis (Customers Analysis)

8.5 Sales Model and Sales Channels

8.5.1 Quetiapine Fumarate Sales Model

8.5.2 Sales Channel

8.5.3 Quetiapine Fumarate Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.2 Data Source

10.2 Author Details

10.3 Disclaimer

FEATURED COMPANIES

SuZhou NO.4 Phamaceutical Factory

Fuan Pharmaceutical

Zhejiang Supor Pharmaceuticals

Zhejiang Huahai Pharmaceutical

Hexal

Intas

Astrazeneca plc

List of Tables

Table 1. Quetiapine Fumarate Market Trends

Table 2. Quetiapine Fumarate Market Drivers & Opportunity

Table 3. Quetiapine Fumarate Market Challenges

Table 4. Quetiapine Fumarate Market Restraints

Table 5. Global Quetiapine Fumarate Revenue by Company (2019-2024) & (US$ Million)

Table 6. Global Quetiapine Fumarate Revenue Market Share by Company (2019-2024)

Table 7. Global Quetiapine Fumarate Sales Volume by Company (2019-2024) & (MT)

Table 8. Global Quetiapine Fumarate Sales Volume Market Share by Company (2019-2024)

Table 9. Global Market Quetiapine Fumarate Price by Company (2019-2024) & (USD/Kg)

Table 10. Key Manufacturers Quetiapine Fumarate Manufacturing Base Distribution and Headquarters

Table 11. Key Manufacturers Quetiapine Fumarate Product Type

Table 12. Key Manufacturers Time to Begin Mass Production of Quetiapine Fumarate

Table 13. Global Quetiapine Fumarate Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Quetiapine Fumarate as of 2023)

Table 15. Mergers & Acquisitions, Expansion Plans

Table 16. Global Quetiapine Fumarate Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)

Table 17. Global Quetiapine Fumarate Sales Value by Type (2019-2024) & (US$ Million)

Table 18. Global Quetiapine Fumarate Sales Value by Type (2025-2030) & (US$ Million)

Table 19. Global Quetiapine Fumarate Sales Market Share in Value by Type (2019-2024) & (%)

Table 20. Global Quetiapine Fumarate Sales Market Share in Value by Type (2025-2030) & (%)

Table 21. Global Quetiapine Fumarate Sales Volume by Type: 2019 VS 2023 VS 2030 (MT)

Table 22. Global Quetiapine Fumarate Sales Volume by Type (2019-2024) & (MT)

Table 23. Global Quetiapine Fumarate Sales Volume by Type (2025-2030) & (MT)

Table 24. Global Quetiapine Fumarate Sales Market Share in Volume by Type (2019-2024) & (%)

Table 25. Global Quetiapine Fumarate Sales Market Share in Volume by Type (2025-2030) & (%)

Table 26. Global Quetiapine Fumarate Price by Type (2019-2024) & (USD/Kg)

Table 27. Global Quetiapine Fumarate Price by Type (2025-2030) & (USD/Kg)

Table 28. Global Quetiapine Fumarate Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)

Table 29. Global Quetiapine Fumarate Sales Value by Application (2019-2024) & (US$ Million)

Table 30. Global Quetiapine Fumarate Sales Value by Application (2025-2030) & (US$ Million)

Table 31. Global Quetiapine Fumarate Sales Market Share in Value by Application (2019-2024) & (%)

Table 32. Global Quetiapine Fumarate Sales Market Share in Value by Application (2025-2030) & (%)

Table 33. Global Quetiapine Fumarate Sales Volume by Application: 2019 VS 2023 VS 2030 (MT)

Table 34. Global Quetiapine Fumarate Sales Volume by Application (2019-2024) & (MT)

Table 35. Global Quetiapine Fumarate Sales Volume by Application (2025-2030) & (MT)

Table 36. Global Quetiapine Fumarate Sales Market Share in Volume by Application (2019-2024) & (%)

Table 37. Global Quetiapine Fumarate Sales Market Share in Volume by Application (2025-2030) & (%)

Table 38. Global Quetiapine Fumarate Price by Application (2019-2024) & (USD/Kg)

Table 39. Global Quetiapine Fumarate Price by Application (2025-2030) & (USD/Kg)

Table 40. Global Quetiapine Fumarate Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Global Quetiapine Fumarate Sales Value by Region (2019-2024) & (US$ Million)

Table 42. Global Quetiapine Fumarate Sales Value by Region (2025-2030) & (US$ Million)

Table 43. Global Quetiapine Fumarate Sales Value by Region (2019-2024) & (%)

Table 44. Global Quetiapine Fumarate Sales Value by Region (2025-2030) & (%)

Table 45. Global Quetiapine Fumarate Sales Volume by Region (MT): 2019 VS 2023 VS 2030

Table 46. Global Quetiapine Fumarate Sales Volume by Region (2019-2024) & (MT)

Table 47. Global Quetiapine Fumarate Sales Volume by Region (2025-2030) & (MT)

Table 48. Global Quetiapine Fumarate Sales Volume by Region (2019-2024) & (%)

Table 49. Global Quetiapine Fumarate Sales Volume by Region (2025-2030) & (%)

Table 50. Global Quetiapine Fumarate Average Price by Region (2019-2024) & (USD/Kg)

Table 51. Global Quetiapine Fumarate Average Price by Region (2025-2030) & (USD/Kg)

Table 52. Key Countries/Regions Quetiapine Fumarate Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030

Table 53. Key Countries/Regions Quetiapine Fumarate Sales Value, (2019-2024) & (US$ Million)

Table 54. Key Countries/Regions Quetiapine Fumarate Sales Value, (2025-2030) & (US$ Million)

Table 55. Key Countries/Regions Quetiapine Fumarate Sales Volume, (2019-2024) & (MT)

Table 56. Key Countries/Regions Quetiapine Fumarate Sales Volume, (2025-2030) & (MT)

Table 57. AstraZeneca Company Information

Table 58. AstraZeneca Introduction and Business Overview

Table 59. AstraZeneca Quetiapine Fumarate Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)

Table 60. AstraZeneca Quetiapine Fumarate Product Offerings

Table 61. AstraZeneca Recent Development

Table 62. Intas Company Information

Table 63. Intas Introduction and Business Overview

Table 64. Intas Quetiapine Fumarate Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)

Table 65. Intas Quetiapine Fumarate Product Offerings

Table 66. Intas Recent Development

Table 67. TAPI Company Information

Table 68. TAPI Introduction and Business Overview

Table 69. TAPI Quetiapine Fumarate Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)

Table 70. TAPI Quetiapine Fumarate Product Offerings

Table 71. TAPI Recent Development

Table 72. Accord Company Information

Table 73. Accord Introduction and Business Overview

Table 74. Accord Quetiapine Fumarate Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)

Table 75. Accord Quetiapine Fumarate Product Offerings

Table 76. Accord Recent Development

Table 77. Hexal Company Information

Table 78. Hexal Introduction and Business Overview

Table 79. Hexal Quetiapine Fumarate Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)

Table 80. Hexal Quetiapine Fumarate Product Offerings

Table 81. Hexal Recent Development

Table 82. Dr.Reddy's Company Information

Table 83. Dr.Reddy's Introduction and Business Overview

Table 84. Dr.Reddy's Quetiapine Fumarate Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)

Table 85. Dr.Reddy's Quetiapine Fumarate Product Offerings

Table 86. Dr.Reddy's Recent Development

Table 87. Lupin Company Information

Table 88. Lupin Introduction and Business Overview

Table 89. Lupin Quetiapine Fumarate Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)

Table 90. Lupin Quetiapine Fumarate Product Offerings

Table 91. Lupin Recent Development

Table 92. Sun Pharmaceutical Company Information

Table 93. Sun Pharmaceutical Introduction and Business Overview

Table 94. Sun Pharmaceutical Quetiapine Fumarate Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)

Table 95. Sun Pharmaceutical Quetiapine Fumarate Product Offerings

Table 96. Sun Pharmaceutical Recent Development

Table 97. Hunan Dongting Pharm Company Information

Table 98. Hunan Dongting Pharm Introduction and Business Overview

Table 99. Hunan Dongting Pharm Quetiapine Fumarate Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)

Table 100. Hunan Dongting Pharm Quetiapine Fumarate Product Offerings

Table 101. Hunan Dongting Pharm Recent Development

Table 102. SuZhou NO.4 Phamaceutical Factory Company Information

Table 103. SuZhou NO.4 Phamaceutical Factory Introduction and Business Overview

Table 104. SuZhou NO.4 Phamaceutical Factory Quetiapine Fumarate Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)

Table 105. SuZhou NO.4 Phamaceutical Factory Quetiapine Fumarate Product Offerings

Table 106. SuZhou NO.4 Phamaceutical Factory Recent Development

Table 107. Fuan Pharmaceutical Company Information

Table 108. Fuan Pharmaceutical Introduction and Business Overview

Table 109. Fuan Pharmaceutical Quetiapine Fumarate Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)

Table 110. Fuan Pharmaceutical Quetiapine Fumarate Product Offerings

Table 111. Fuan Pharmaceutical Recent Development

Table 112. Zhejiang Supor Pharmaceuticals Company Information

Table 113. Zhejiang Supor Pharmaceuticals Introduction and Business Overview

Table 114. Zhejiang Supor Pharmaceuticals Quetiapine Fumarate Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)

Table 115. Zhejiang Supor Pharmaceuticals Quetiapine Fumarate Product Offerings

Table 116. Zhejiang Supor Pharmaceuticals Recent Development

Table 117. Zhejiang Huahai Pharmaceutical Company Information

Table 118. Zhejiang Huahai Pharmaceutical Introduction and Business Overview

Table 119. Zhejiang Huahai Pharmaceutical Quetiapine Fumarate Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)

Table 120. Zhejiang Huahai Pharmaceutical Quetiapine Fumarate Product Offerings

Table 121. Zhejiang Huahai Pharmaceutical Recent Development

Table 122. Key Raw Materials Lists

Table 123. Raw Materials Key Suppliers Lists

Table 124. Quetiapine Fumarate Downstream Customers

Table 125. Quetiapine Fumarate Distributors List

Table 126. Research Programs/Design for This Report

Table 127. Key Data Information from Secondary Sources

Table 128. Key Data Information from Primary Sources

List of Figures

Figure 1. Quetiapine Fumarate Product Picture

Figure 2. Global Quetiapine Fumarate Sales Value, 2019 VS 2023 VS 2030 (US$ Million)

Figure 3. Global Quetiapine Fumarate Sales Value (2019-2030) & (US$ Million)

Figure 4. Global Quetiapine Fumarate Sales Volume (2019-2030) & (MT)

Figure 5. Global Quetiapine Fumarate Sales Price (2019-2030) & (USD/Kg)

Figure 6. Quetiapine Fumarate Report Years Considered

Figure 7. Global Quetiapine Fumarate Players Revenue Ranking (2023) & (US$ Million)

Figure 8. Global Quetiapine Fumarate Players Sales Volume Ranking (2023) & (MT)

Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Quetiapine Fumarate Revenue in 2023

Figure 10. Quetiapine Fumarate Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 11. Immediate Release Tablets Picture

Figure 12. Extended Release Tablets Picture

Figure 13. Global Quetiapine Fumarate Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)

Figure 14. Global Quetiapine Fumarate Sales Value Market Share by Type, 2023 & 2030

Figure 15. Global Quetiapine Fumarate Sales Volume by Type (2019 VS 2023 VS 2030) & (MT)

Figure 16. Global Quetiapine Fumarate Sales Volume Market Share by Type, 2023 & 2030

Figure 17. Global Quetiapine Fumarate Price by Type (2019-2030) & (USD/Kg)

Figure 18. Product Picture of Adult

Figure 19. Product Picture of Others

Figure 20. Global Quetiapine Fumarate Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)

Figure 21. Global Quetiapine Fumarate Sales Value Market Share by Application, 2023 & 2030

Figure 22. Global Quetiapine Fumarate Sales Volume by Application (2019 VS 2023 VS 2030) & (MT)

Figure 23. Global Quetiapine Fumarate Sales Volume Market Share by Application, 2023 & 2030

Figure 24. Global Quetiapine Fumarate Price by Application (2019-2030) & (USD/Kg)

Figure 25. North America Quetiapine Fumarate Sales Value (2019-2030) & (US$ Million)

Figure 26. North America Quetiapine Fumarate Sales Value by Country (%), 2023 VS 2030

Figure 27. Europe Quetiapine Fumarate Sales Value (2019-2030) & (US$ Million)

Figure 28. Europe Quetiapine Fumarate Sales Value by Country (%), 2023 VS 2030

Figure 29. Asia Pacific Quetiapine Fumarate Sales Value (2019-2030) & (US$ Million)

Figure 30. Asia Pacific Quetiapine Fumarate Sales Value by Country (%), 2023 VS 2030

Figure 31. South America Quetiapine Fumarate Sales Value (2019-2030) & (US$ Million)

Figure 32. South America Quetiapine Fumarate Sales Value by Country (%), 2023 VS 2030

Figure 33. Middle East & Africa Quetiapine Fumarate Sales Value (2019-2030) & (US$ Million)

Figure 34. Middle East & Africa Quetiapine Fumarate Sales Value by Country (%), 2023 VS 2030

Figure 35. Key Countries/Regions Quetiapine Fumarate Sales Value (%), (2019-2030)

Figure 36. Key Countries/Regions Quetiapine Fumarate Sales Volume (%), (2019-2030)

Figure 37. United States Quetiapine Fumarate Sales Value, (2019-2030) & (US$ Million)

Figure 38. United States Quetiapine Fumarate Sales Value by Type (%), 2023 VS 2030

Figure 39. United States Quetiapine Fumarate Sales Value by Application (%), 2023 VS 2030

Figure 40. Europe Quetiapine Fumarate Sales Value, (2019-2030) & (US$ Million)

Figure 41. Europe Quetiapine Fumarate Sales Value by Type (%), 2023 VS 2030

Figure 42. Europe Quetiapine Fumarate Sales Value by Application (%), 2023 VS 2030

Figure 43. China Quetiapine Fumarate Sales Value, (2019-2030) & (US$ Million)

Figure 44. China Quetiapine Fumarate Sales Value by Type (%), 2023 VS 2030

Figure 45. China Quetiapine Fumarate Sales Value by Application (%), 2023 VS 2030

Figure 46. Japan Quetiapine Fumarate Sales Value, (2019-2030) & (US$ Million)

Figure 47. Japan Quetiapine Fumarate Sales Value by Type (%), 2023 VS 2030

Figure 48. Japan Quetiapine Fumarate Sales Value by Application (%), 2023 VS 2030

Figure 49. South Korea Quetiapine Fumarate Sales Value, (2019-2030) & (US$ Million)

Figure 50. South Korea Quetiapine Fumarate Sales Value by Type (%), 2023 VS 2030

Figure 51. South Korea Quetiapine Fumarate Sales Value by Application (%), 2023 VS 2030

Figure 52. Southeast Asia Quetiapine Fumarate Sales Value, (2019-2030) & (US$ Million)

Figure 53. Southeast Asia Quetiapine Fumarate Sales Value by Type (%), 2023 VS 2030

Figure 54. Southeast Asia Quetiapine Fumarate Sales Value by Application (%), 2023 VS 2030

Figure 55. India Quetiapine Fumarate Sales Value, (2019-2030) & (US$ Million)

Figure 56. India Quetiapine Fumarate Sales Value by Type (%), 2023 VS 2030

Figure 57. India Quetiapine Fumarate Sales Value by Application (%), 2023 VS 2030

Figure 58. Quetiapine Fumarate Industrial Chain

Figure 59. Quetiapine Fumarate Manufacturing Cost Structure

Figure 60. Channels of Distribution (Direct Sales, and Distribution)

Figure 61. Bottom-up and Top-down Approaches for This Report

Figure 62. Data Triangulation

Figure 63. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$3950

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions